The EGFR variant III mutant as a target for immunotherapy of glioblastoma multiforme
Sign Up to like & getrecommendations! Published in 2017 at "European Journal of Pharmacology"
DOI: 10.1016/j.ejphar.2017.05.064
Abstract: ABSTRACT In epithelial tumors, the epidermal growth factor receptor (EGFR) controls key signaling pathways responsible for growth, proliferation, migration, and survival of tumor cells. The epidermal growth factor receptor variant III (EGFRvIII) is the most… read more here.
Keywords: egfr; egfrviii; glioblastoma multiforme; variant iii ... See more keywords